260 related articles for article (PubMed ID: 28552843)
1. Cost of elective percutaneous coronary intervention in Malaysia: a multicentre cross-sectional costing study.
Lee KY; Ong TK; Low EV; Liow SY; Anchah L; Hamzah S; Liew HB; Ali RM; Ismail O; Ahmad WAW; Said MA; Dahlui M
BMJ Open; 2017 May; 7(5):e014307. PubMed ID: 28552843
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the treatment practice and hospitalization cost of percutaneous coronary intervention between a teaching hospital and a general hospital in Malaysia: A cross sectional study.
Lee KY; Wan Ahmad WA; Low EV; Liau SY; Anchah L; Hamzah S; Liew HB; Mohd Ali RB; Ismail O; Ong TK; Said MA; Dahlui M
PLoS One; 2017; 12(9):e0184410. PubMed ID: 28873473
[TBL] [Abstract][Full Text] [Related]
3. Costs of transradial percutaneous coronary intervention.
Amin AP; House JA; Safley DM; Chhatriwalla AK; Giersiefen H; Bremer A; Hamon M; Baklanov DV; Aluko A; Wohns D; Mathias DW; Applegate RA; Cohen DJ; Marso SP
JACC Cardiovasc Interv; 2013 Aug; 6(8):827-34. PubMed ID: 23871512
[TBL] [Abstract][Full Text] [Related]
4. Costs Associated With Access Site and Same-Day Discharge Among Medicare Beneficiaries Undergoing Percutaneous Coronary Intervention: An Evaluation of the Current Percutaneous Coronary Intervention Care Pathways in the United States.
Amin AP; Patterson M; House JA; Giersiefen H; Spertus JA; Baklanov DV; Chhatriwalla AK; Safley DM; Cohen DJ; Rao SV; Marso SP
JACC Cardiovasc Interv; 2017 Feb; 10(4):342-351. PubMed ID: 28231901
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of percutaneous coronary intervention versus bypass surgery from a Dutch perspective.
Osnabrugge RL; Magnuson EA; Serruys PW; Campos CM; Wang K; van Klaveren D; Farooq V; Abdallah MS; Li H; Vilain KA; Steyerberg EW; Morice MC; Dawkins KD; Mohr FW; Kappetein AP; Cohen DJ;
Heart; 2015 Dec; 101(24):1980-8. PubMed ID: 26552756
[TBL] [Abstract][Full Text] [Related]
6. Association of Same-Day Discharge After Elective Percutaneous Coronary Intervention in the United States With Costs and Outcomes.
Amin AP; Pinto D; House JA; Rao SV; Spertus JA; Cohen MG; Pancholy S; Salisbury AC; Mamas MA; Frogge N; Singh J; Lasala J; Masoudi FA; Bradley SM; Wasfy JH; Maddox TM; Kulkarni H
JAMA Cardiol; 2018 Nov; 3(11):1041-1049. PubMed ID: 30267035
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial.
Cohen DJ; Osnabrugge RL; Magnuson EA; Wang K; Li H; Chinnakondepalli K; Pinto D; Abdallah MS; Vilain KA; Morice MC; Dawkins KD; Kappetein AP; Mohr FW; Serruys PW;
Circulation; 2014 Sep; 130(14):1146-57. PubMed ID: 25085960
[TBL] [Abstract][Full Text] [Related]
8. Prevalence, Outcomes and Cost Implications of Patients Undergoing Same Day Discharge After Elective Percutaneous Coronary Intervention in Australia.
Liew S; Dinh D; Liew D; Brennan A; Duffy S; Reid C; Lefkovits J; Stub D;
Heart Lung Circ; 2020 Aug; 29(8):e185-e193. PubMed ID: 31791887
[TBL] [Abstract][Full Text] [Related]
9. Appropriateness of elective percutaneous coronary intervention and impact of government health insurance scheme - A tertiary centre experience from Western India.
Patil D; Lanjewar C; Vaggar G; Bhargava J; Sabnis G; Pahwa J; Phatarpekar A; Shah H; Kerkar P
Indian Heart J; 2017; 69(5):600-606. PubMed ID: 29054183
[TBL] [Abstract][Full Text] [Related]
10. Cost of single-vessel and multivessel coronary drug-eluting stenting: comparison to the DRG funding level.
Varani E; Balducelli M; Gatti C; Tesselli MR; Vecchi G; Maresta A
Ital Heart J; 2005 Jan; 6(1):52-8. PubMed ID: 15773274
[TBL] [Abstract][Full Text] [Related]
11. Annual cost of stable coronary artery disease in France: A modeling study.
Caruba T; Chevreul K; Zarca K; Cadier B; Juillière Y; Dubourg O; Sabatier B; Danchin N
Arch Cardiovasc Dis; 2015 Nov; 108(11):576-88. PubMed ID: 26433733
[TBL] [Abstract][Full Text] [Related]
12. Cost effectiveness of radial access for diagnostic cardiac catheterization and coronary intervention.
Applegate R; Sacrinty M; Schafer P; Smith J; Gandhi S; Kutcher M; Santos R; Cecile A; Little W
Catheter Cardiovasc Interv; 2013 Oct; 82(4):E375-84. PubMed ID: 23074085
[TBL] [Abstract][Full Text] [Related]
13. Manual Compression versus Vascular Closing Device for Closing Access Puncture Site in Femoral Left-Heart Catheterization and Percutaneous Coronary Interventions: A Retrospective Cross-Sectional Comparison of Costs and Effects in Inpatient Care.
Walter J; Vogl M; Holderried M; Becker C; Brandes A; Sinner MF; Rogowski W; Maschmann J
Value Health; 2017 Jun; 20(6):769-776. PubMed ID: 28577694
[TBL] [Abstract][Full Text] [Related]
14. Improving the quality of percutaneous revascularisation in patients with multivessel disease in Australia: cost-effectiveness, public health implications, and budget impact of FFR-guided PCI.
Siebert U; Arvandi M; Gothe RM; Bornschein B; Eccleston D; Walters DL; Rankin J; De Bruyne B; Fearon WF; Pijls NH; Harper R
Heart Lung Circ; 2014 Jun; 23(6):527-33. PubMed ID: 24560401
[TBL] [Abstract][Full Text] [Related]
15. Coronary Artery Bypass Graft Surgery Cost Coverage by the Brazilian Unified Health System (SUS).
Silva GSD; Colósimo FC; Sousa AG; Piotto RF; Castilho V
Braz J Cardiovasc Surg; 2017; 32(4):253-259. PubMed ID: 28977196
[TBL] [Abstract][Full Text] [Related]
16. Appropriateness-based reimbursement of elective invasive coronary procedures in low- and middle-income countries: Preliminary assessment of feasibility in India.
Karthikeyan G; Shirodkar U; Lochan MR; Birch S
Natl Med J India; 2017; 30(1):11-14. PubMed ID: 28731000
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness and Outcomes with Early or Same-Day Discharge After Elective Percutaneous Coronary Intervention.
Koshy SKG; George LK; Das P
Curr Cardiol Rep; 2020 May; 22(6):42. PubMed ID: 32430629
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of percutaneous coronary intervention in patients with stable coronary artery disease and abnormal fractional flow reserve.
Fearon WF; Shilane D; Pijls NH; Boothroyd DB; Tonino PA; Barbato E; Jüni P; De Bruyne B; Hlatky MA;
Circulation; 2013 Sep; 128(12):1335-40. PubMed ID: 23946263
[TBL] [Abstract][Full Text] [Related]
19. Regional to tertiary inter-hospital transfer versus in-house percutaneous coronary intervention in acute coronary syndrome.
Javat D; Heal C; Banks J; Buchholz S; Zhang Z
PLoS One; 2018; 13(6):e0198272. PubMed ID: 29927947
[TBL] [Abstract][Full Text] [Related]
20. Cost awareness decreases total percutaneous coronary intervention procedural cost: The SHOPPING (Show How Options in Price for Procedures Can Be Influenced Greatly) trial.
Asher E; Mansour J; Wheeler A; Kendrick D; Cunningham M; Parikh S; Zidar D; Harford T; Simon DI; Kashyap VS
Catheter Cardiovasc Interv; 2017 Jun; 89(7):1207-1212. PubMed ID: 27862875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
